These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2014214)

  • 1. The solubility-modulated osmotic pump: in vitro/in vivo release of diltiazem hydrochloride.
    McClelland GA; Sutton SC; Engle K; Zentner GM
    Pharm Res; 1991 Jan; 8(1):88-92. PubMed ID: 2014214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.
    Shokri J; H Zarrintan M; Ghanbarzadeh S; Arash Z; Farahani A; Adibkia K
    Drug Res (Stuttg); 2013 Aug; 63(8):414-9. PubMed ID: 23599037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
    Song QL; Li P; Li YM
    Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled porosity osmotic pumps of highly aqueous soluble drug containing hydrophilic polymers as release retardants.
    Prabakaran D; Singh P; Kanaujia P; Mishra V; Jaganathan KS; Vyas SP
    Pharm Dev Technol; 2004 Nov; 9(4):435-42. PubMed ID: 15581079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps.
    Prabakaran D; Singh P; Kanaujia P; Vyas SP
    Int J Pharm; 2003 Jun; 259(1-2):173-9. PubMed ID: 12787645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of diltiazem tablet and multiparticulate osmotic formulations in the dog.
    Sutton SC; Engle K; Deeken RA; Plute KE; Shaffer RD
    Pharm Res; 1990 Aug; 7(8):874-8. PubMed ID: 2235885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of multiparticulate sustained-release diltiazem preparations in dogs.
    Murata K; Noda K
    J Pharm Sci; 1994 Jan; 83(1):38-41. PubMed ID: 8138907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-carboxymethyl-O-ethylcyclomaltoheptaose as a delayed-release-type drug carrier: improvement of the oral bioavailability of diltiazem in the dog.
    Uekama K; Horiuchi Y; Irie T; Hirayama F
    Carbohydr Res; 1989 Oct; 192():323-30. PubMed ID: 2611776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.
    Adibkia K; Ghanbarzadeh S; Shokri MH; Arami Z; Arash Z; Shokri J
    Pharm Dev Technol; 2014 Jun; 19(4):507-12. PubMed ID: 23763379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption of diltiazem in beagle dog from pulsatile release tablet.
    Ishino R; Yoshino H; Hirakawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3094-6. PubMed ID: 1477926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
    Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
    Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride.
    Al-Saidan SM; Krishnaiah YS; Patro SS; Satyanaryana V
    AAPS PharmSciTech; 2005 Jul; 6(1):E14-21. PubMed ID: 16353958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.
    Li S; Wang X; Wang Y; Zhao Q; Zhang L; Yang X; Liu D; Pan W
    Drug Dev Ind Pharm; 2015; 41(12):2089-99. PubMed ID: 26304493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-suspension coating method: a new approach in formulation and development of controlled porosity osmotic pump systems.
    Adibkia K; Hanaee J; Ghanbarzadeh S; Bahrami R; Shokri J
    Drug Res (Stuttg); 2014 Apr; 64(4):203-7. PubMed ID: 24026954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride.
    Kim H; Fassihi R
    Pharm Res; 1997 Oct; 14(10):1415-21. PubMed ID: 9358555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal transit monitoring and absorption of controlled-release pellets of diltiazem.
    Rahman NU; Yuen KH; Woei WJ
    Pharm Dev Technol; 2005; 10(3):371-9. PubMed ID: 16176017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diltiazem multi-dose gastrointestinal diffusion system: preparation and release rate studies.
    Janicki S; Jedras Z
    Farmaco; 1989 May; 44(5):531-9. PubMed ID: 2789629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system.
    Gong W; Liu Y; Mei DY; Yang M; Mei XG
    Drug Dev Ind Pharm; 2015 Mar; 41(3):464-9. PubMed ID: 24400982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.